MedPath

Ribomustin

Brand Name: Ribomustin

Generic Name: Bendamustine Hydrochloride

Expiring Soon
Registration Number

DR-XY44831

Dosage Form

Lyophilized Powder For Concentrate For Solution For IV Infusion

Issuance Date

May 13, 2022

Expiry Date

September 22, 2025

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength25 mg
PackagingType I brown glass vial with grey bromobutyl rubber stopper and blue polypropylene disc aluminum flip-off cap (Box of 1's)

Classification

C
Classification
Prescription Drug (RX)
P
Pharmacologic
Alkylating Agent
A
Application
Initial (from Monitored Release)
Philippine FDA Classification

Active Ingredients (1)

Complete list of active ingredients in this pharmaceutical product.

Bendamustine HydrochlorideActive
Monograph: Bendamustine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform